NEW ORLEANS – The landscape of reconstructive medicine has entered a new chapter as The Plastic Surgery Foundation (The PSF)—the philanthropic and research arm of the American Society of Plastic Surgeons (ASPS)—formally inaugurated Babak J. Mehrara, MD, as its president. The transition of leadership occurred on October 12, 2025, during Plastic Surgery The Meeting in New Orleans, the premier annual scientific summit for the specialty.
Dr. Mehrara, an internationally renowned authority in oncologic reconstruction and lymphatic biology, steps into this role with a mandate to bridge the gap between bench-side laboratory research and bedside clinical application. His presidency, which runs through October 18, 2026, is expected to prioritize the development of early-career investigators and the scaling of global surgical education initiatives.
The Appointment: A Strategic Vision for The PSF
The appointment of Dr. Mehrara represents a strategic alignment for The PSF. As the organization navigates an era defined by rapid technological advancements—including regenerative medicine, robotic-assisted surgery, and artificial intelligence—the Foundation seeks a leader capable of managing both the rigor of clinical research and the humanitarian outreach that defines modern plastic surgery.
"It is an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated during his inaugural address at the New Orleans conference. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
Chronology: A Career Built on Scientific Rigor
Dr. Mehrara’s ascent to the presidency of The PSF is the culmination of a decades-long career defined by academic precision and patient advocacy. His trajectory reflects a dual commitment to surgical mastery and the pursuit of fundamental scientific truths.
- Foundational Years: Developing a deep expertise in reconstructive techniques, Dr. Mehrara established himself early as a specialist in the complex challenges of oncologic reconstruction.
- Academic Leadership: Dr. Mehrara currently serves as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK) in New York. His leadership at MSK has been pivotal in integrating high-volume surgical practice with a robust research environment.
- The Lymphatic Biology Laboratory: As the director of the NIH-funded Lymphatic Biology Laboratory, Dr. Mehrara has spearheaded research that has fundamentally changed the understanding of lymphedema—a debilitating condition affecting millions of cancer survivors.
- Academic Professorship: In his capacity as Professor of Surgery at Weill Cornell Medical College, he has mentored a new generation of surgeons, ensuring that the legacy of evidence-based practice is passed down to residents and fellows.
- October 12, 2025: Dr. Mehrara officially assumes the presidency of The PSF at Plastic Surgery The Meeting.
- October 18, 2026: Scheduled conclusion of his presidential term.
Supporting Data: The Weight of Clinical Expertise
To understand the gravity of Dr. Mehrara’s appointment, one must look at the data supporting his professional footprint. He is not merely a surgeon; he is a prolific contributor to the medical literature. With more than 400 peer-reviewed publications to his name, his work has provided the empirical foundation for many modern reconstructive protocols.
His expertise in the surgical and nonsurgical treatment of cancer-related lymphedema is particularly significant. As an NIH-funded principal investigator, his research at the Lymphatic Biology Laboratory has moved the needle on treatments that were previously considered palliative, shifting the focus toward curative and regenerative interventions.
The Peter G. Cordeiro Endowed Chair in the Department of Surgery at MSK, which he currently holds, serves as a testament to his standing within the most elite echelons of surgical academia. This endowment is awarded only to those who demonstrate exceptional commitment to the advancement of surgical science, a metric Dr. Mehrara has consistently exceeded throughout his tenure.
Official Responses and Stakeholder Perspectives
The selection of Dr. Mehrara was met with widespread approval from the surgical community. Peers and organizational leaders have noted that his unique blend of "clinical pragmatism and scientific curiosity" makes him the ideal candidate to steer the Foundation through its next cycle of growth.
The Foundation’s Perspective
Board members at The PSF have emphasized that Dr. Mehrara’s appointment is designed to facilitate closer partnerships with governmental and private research entities. By leveraging his existing relationships with the National Institutes of Health (NIH), The PSF expects to increase the volume of grants available to young surgeons who are often discouraged by the "funding gap" in early-career research.
Institutional Support
Leadership at Memorial Sloan Kettering Cancer Center has hailed the appointment as a significant milestone, noting that Dr. Mehrara’s presidency will elevate the visibility of the "oncologic reconstruction" sub-specialty. By positioning a cancer-focused reconstructive surgeon at the helm of the field’s largest foundation, the institution reinforces its commitment to multidisciplinary care.
Implications: The Future of Plastic Surgery
Dr. Mehrara’s presidency is expected to be marked by three primary strategic pillars:
1. Nurturing the "Research Pipeline"
The most pressing challenge in medical innovation is the retention of physician-scientists. Dr. Mehrara has signaled that he intends to dedicate a significant portion of the Foundation’s budget to "bridge grants"—funding that supports residents and junior faculty during the precarious period between completing training and securing their first major independent research grants.
2. Expanding Global Access and Affordability
A core component of The PSF’s mandate is the promotion of safe and effective plastic surgery globally. Under Dr. Mehrara, the Foundation is poised to expand its international education initiatives. By exporting best practices in reconstructive safety to low-resource settings, the Foundation aims to reduce the global burden of surgical complications.
3. Digitization of Surgical Data
With his background in laboratory-based research, Dr. Mehrara is an advocate for the integration of "big data" into plastic surgery. He is expected to champion initiatives that utilize AI and machine learning to analyze long-term patient outcomes, thereby refining surgical techniques to minimize morbidity and maximize aesthetic and functional success.
Conclusion: A Legacy in the Making
As Dr. Mehrara embarks on his tenure, the expectations are high. The intersection of oncology and plastic surgery is a rapidly evolving field, and the decisions made during his presidency will likely dictate the trajectory of reconstructive care for the next decade.
By balancing the heavy responsibilities of clinical leadership at one of the world’s most prestigious cancer centers with the administrative and visionary demands of The Plastic Surgery Foundation, Dr. Mehrara embodies the modern "surgeon-scientist." His tenure promises not only to honor the long-standing traditions of the American Society of Plastic Surgeons but to propel the specialty into a future defined by high-impact research, global outreach, and an unwavering commitment to the patient experience.
As the medical community watches his progress, it is clear that the Foundation has chosen a leader whose own career serves as a blueprint for the progress he intends to achieve. With a firm grip on the current state of surgical science and a clear eye toward the innovations of tomorrow, Dr. Babak J. Mehrara is poised to leave an indelible mark on the field of plastic and reconstructive surgery.
About the Author
